Real-world effectiveness of sofosbuvir/velpatasvir, glecaprevir/pibrentasvir, and sofosbuvir/velpatasvir/voxilaprevir against genotype 3 hepatitis C virus infection: a systematic review and meta-analysis

Real-world effectiveness of sofosbuvir/velpatasvir, glecaprevir/pibrentasvir, and sofosbuvir/velpatasvir/voxilaprevir against genotype 3 hepatitis C virus infection: a systematic review and meta-analysis

IntroductionDirect antiviral agents (DAAs) have dramatically changed the landscape of liver diseases associated with chronic hepatitis C virus (HCV) infection. However, limited data are available on the antiviral effect of sofosbuvir (SOF) + velpatasvir (VEL) ± ribavirin (RBV), SOF + VEL + voxilapre...

Full description

Saved in:

Bibliographic Details
Main Authors:	Liwei Zhuang, Junnan Li, Yu Zhang, Shibo Ji, Huichun Xing
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Gastroenterology
Subjects:	real-world effectiveness sofosbuvir/velpatasvir glecaprevir/pibrentasvir sofosbuvir/velpatasvir/voxilaprevir genotype 3 HCV
Online Access:	https://www.frontiersin.org/articles/10.3389/fgstr.2025.1511150/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Real-life study on the effectiveness and safety of sofosbuvir/velpatasvir-based antiviral agents for hepatitis C eradication in Chinese patients
by: Jiayi Wang, et al.
Published: (2024-12-01)

The Efficacy and Safety of Sofosbuvir Containing Regimen in the Treatment of Hcv Infection in Patients with Haemoglobinopathy
by: Nawfal R Hussein
Published: (2017-01-01)

Ocular manifestations and treatment safety in hepatitis C patients undergoing direct-acting antiviral therapy: a prospective cohort study
by: Guilherme Thomé de Carvalho, et al.
Published: (2025-02-01)

Real-life results of sofosbuvir based therapy for patients with hepatitis C
by: D. G. Zhivitsa, et al.
Published: (2019-09-01)

Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide
by: Aleksandra Berkan-Kawińska, et al.
Published: (2024-07-01)

The impact of sofosbuvir/ledipasvir on chronic hepatitis C-infected paediatric patients: a Middle East single-centre experience
by: Mohammad Fadhil Ibraheem, et al.
Published: (2023-11-01)

Assessment of Glecaprevir/Pibrentasvir Treatment’s Influence on Biochemical and Metabolic Markers in Patients with Chronic Hepatitis
by: Alina Maria Constantinescu, et al.
Published: (2024-11-01)

Acute kidney injury and ANCA positivity in a patient treated with glecaprevir/pibrentasvir: a case report
by: Lawrence Hyun Kwon, et al.
Published: (2025-01-01)

Direct-Acting Antivirals in Hepatitis C Treatment for Renal Impairment: Liver Safety Concerns and Effectiveness in Peritoneal Dialysis
by: Hsuan-Yu Hung, et al.
Published: (2024-12-01)

Comparative Antiviral Efficacy of Generic Sofosbuvir versus Brand Name Sofosbuvir with Ribavirin for the Treatment of Hepatitis C
by: L. Tang, et al.
Published: (2018-01-01)

In silico analysis of the effect of HCV genotype-specific polymorphisms in Core, NS3, NS5A, and NS5B proteins on T-cell epitope processing and presentation
by: Samina Baig, et al.
Published: (2025-01-01)

Impact of Age and Sex on Viral Load in Hepatitis C Virus Infection
by: Andrea Magri, et al.
Published: (2024-12-01)

Investigation of Hepatitis C (HCV) Virus Epidemiology in the Capital City of Türkiye
by: Fatih Mehmet Akıllı
Published: (2024-12-01)

Long-term outcome in people who use drugs successfully treated for hepatitis C infection with glecaprevir/pibrentasvir
by: Shana Yi, et al.
Published: (2024-12-01)

OCCULT HEPATITIS B VIRUS INFECTION AND ASSOCIATED GENOTYPES AMONG HBSAG-NEGATIVE SUBJECTS IN BURKINA FASO
by: Birama DIARRA, et al.
Published: (2018-01-01)

Genotype 3 is linked to worse liver disease progression in hepatitis C patients even after SVR following DAA therapy
by: Xiping Ran, et al.
Published: (2025-02-01)

Development of Virus-Like Particles (VLPs) for Hepatitis C Virus genotype 4: a novel approach for vaccine development in Egypt
by: Ahmed A. Ali, et al.
Published: (2025-01-01)

Efficacy and Safety of Sofosbuvir-Based Direct-Acting Antiviral Agents Treatment for Patients with Genotype 3/6 Hepatitis C Virus Infection
by: Yong-yu Mei, et al.
Published: (2020-01-01)

Safety of Sofosbuvir and Ribavirin Combination Therapy in a Patient Who Developed Anemia due to Ribavirin
by: Hirokazu Suii, et al.
Published: (2017-01-01)

Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) in HCV-Positive Egyptian Patients Treated with Sofosbuvir
by: Ali Nada, et al.
Published: (2020-01-01)

Sofosbuvir-Based Therapies for Patients with Hepatitis C Virus Infection: Real-World Experience in China
by: Chengguang Hu, et al.
Published: (2018-01-01)

Sofosbuvir Based Regimens in the Treatment of Chronic Hepatitis C with Compensated Liver Cirrhosis in Community Care Setting
by: Vijay Gayam, et al.
Published: (2018-01-01)

An Unexpected Interaction between Sofosbuvir/Ledipasvir and Atorvastatin and Colchicine Causing Rhabdomyolysis in a Patient with Impaired Renal Function
by: Shyam Patel, et al.
Published: (2016-01-01)

Resistance-Associated Substitutions (RAS) and Clinical Factors as Determinants of Sofosbuvir-Daclatasvir Treatment Outcomes in Chronic Hepatitis C Patients
by: Juferdy Kurniawan, et al.
Published: (2024-10-01)

Successful Treatment of Hepatitis C with Simeprevir, Sofosbuvir, and Ribavirin in an HIV Coinfected Liver Transplant Patient with Advanced Chronic Kidney Disease
by: Anna Maruyama, et al.
Published: (2016-01-01)

Daclatasvir and Sofosbuvir Therapy Enhance Monocyte Phenotypic Changes in Naive Chronic Hepatitis C Patients: A Prospective Cohort Study
by: Hanan M. Fayed, et al.
Published: (2019-01-01)

GENOTYPIC DIVERSITY OF DENGUE VIRUS IN AEDES MOSQUITOES COLLECTED FROM DENGUE HOTSPOT AREAS IN KUALA LUMPUR AND SELANGOR, MALAYSIA
by: Wan Najdah Wan Mohamad Ali, et al.
Published: (2023-04-01)

Genotypic-Phenotypic Diversity in Beta Thalassemia
by: Ravindra Kumar, et al.
Published: (2014-08-01)

Simeprevir and Sofosbuvir Combination Treatment in a Patient with HCV Cirrhosis and HbS Beta 0-Thalassemia: Efficacy and Safety despite Baseline Hyperbilirubinemia
by: Nikolaos Papadopoulos, et al.
Published: (2016-01-01)

Сучасний погляд на профілактику акушерських та перинатальних ускладнень у жінок із HCV-інфекцією
by: K.V. Chaika, et al.
Published: (2022-03-01)

Hepatitis C Virus NS5A Activates Mitophagy Through Cargo Receptor and Phagophore Formation
by: Yuan-Chao Hsiao, et al.
Published: (2024-12-01)

Autoimmunity and Lymphoma: Splenic Marginal Zone Lymphoma with Scleroderma and Chronic Hepatitis C Virus infection.
by: Ricardo García-Muñoz
Published: (2014-08-01)

Mean Performance of Field pea (Pisum sativum L) Advanced Genotypes for Yield and Yield-related Traits in Arsi Zone, Ethiopia
by: Gebeyaw Achenef, et al.
Published: (2024-12-01)

A Study on the Genotype × Environment Interaction in Promising Advanced Genotypes of Soybean using Graphical GGE-biplot Analysis
by: Bahram Masoudi, et al.
Published: (2024-11-01)

Development of a Robust UPLC Method for Simultaneous Determination of a Novel Combination of Sofosbuvir and Daclatasvir in Human Plasma: Clinical Application to Therapeutic Drug Monitoring
by: Naser F. Al-Tannak, et al.
Published: (2018-01-01)

Predictors of response to daclatasvir in addition to sofosbuvir in hepatitis C virus-infected patients with stage 4 and 5 chronic kidney disease and patients on maintenance hemodialysis
by: Rasha Gawish, et al.
Published: (2025-01-01)

Genotypic variability for root nodulation and identification of high yielding chickpea (Cicer arietinum L.) genotypes
by: Jyoti Kumari, Rafat Sultana*, Zafar Imam, Mankesh Kumar and Reena Kumari
Published: (2024-12-01)

GENOTYPIC AND MODIFICATIONAL VARIABILITY OF THE PASSIVE DEFENSE RESPONSE TO HUMANS IN DOMESTIC PIGS
by: V. S. Lankin
Published: (2015-01-01)

Efficacy and safety of 3D-therapy at HCV-related subcompensated liver cirrhosis (genotype 1b)
by: P. O. Bogomolov, et al.
Published: (2018-08-01)

Frequency of BK virus genotypes in patients with colorectal cancer
by: Mahsa Javadi, et al.
Published: (2025-02-01)